CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 154 filers reported holding CONMED CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,701,005 | -6.9% | 67,816 | +7.6% | 0.03% | -19.4% |
Q1 2024 | $5,047,843 | -27.8% | 63,035 | -1.2% | 0.04% | -30.8% |
Q4 2023 | $6,988,381 | +82.4% | 63,815 | +68.0% | 0.05% | +92.6% |
Q3 2023 | $3,831,695 | -48.0% | 37,994 | -30.0% | 0.03% | -47.1% |
Q2 2023 | $7,374,886 | +32.5% | 54,271 | +1.2% | 0.05% | +27.5% |
Q1 2023 | $5,568,038 | +13.3% | 53,611 | -3.3% | 0.04% | +5.3% |
Q4 2022 | $4,915,531 | +109695.2% | 55,455 | -0.7% | 0.04% | 0.0% |
Q3 2022 | $4,477 | -99.9% | 55,844 | +2.3% | 0.04% | -13.6% |
Q2 2022 | $5,228,000 | -35.5% | 54,592 | 0.0% | 0.04% | -10.2% |
Q1 2022 | $8,110,000 | -4.0% | 54,592 | -8.4% | 0.05% | +8.9% |
Q4 2021 | $8,445,000 | +9.5% | 59,572 | +1.1% | 0.04% | +2.3% |
Q3 2021 | $7,710,000 | -5.6% | 58,932 | -0.9% | 0.04% | -10.2% |
Q2 2021 | $8,169,000 | +6.1% | 59,442 | +0.8% | 0.05% | -2.0% |
Q1 2021 | $7,701,000 | +8.7% | 58,972 | -6.8% | 0.05% | -7.4% |
Q4 2020 | $7,084,000 | +42.4% | 63,252 | 0.0% | 0.05% | +35.0% |
Q3 2020 | $4,976,000 | +2.8% | 63,252 | -6.0% | 0.04% | -11.1% |
Q2 2020 | $4,842,000 | +33.0% | 67,261 | +5.8% | 0.04% | +7.1% |
Q1 2020 | $3,640,000 | -48.8% | 63,562 | 0.0% | 0.04% | -4.5% |
Q4 2019 | $7,108,000 | +2.9% | 63,562 | -11.5% | 0.04% | -4.3% |
Q3 2019 | $6,910,000 | +41.0% | 71,862 | +25.5% | 0.05% | +17.9% |
Q2 2019 | $4,900,000 | +148.0% | 57,258 | +141.0% | 0.04% | +116.7% |
Q1 2019 | $1,976,000 | +35.8% | 23,758 | +4.9% | 0.02% | +50.0% |
Q4 2018 | $1,455,000 | +2.2% | 22,658 | +26.2% | 0.01% | +20.0% |
Q3 2018 | $1,423,000 | +20.5% | 17,958 | +11.3% | 0.01% | +25.0% |
Q2 2018 | $1,181,000 | +18.6% | 16,128 | +2.5% | 0.01% | +14.3% |
Q1 2018 | $996,000 | +24.2% | 15,728 | 0.0% | 0.01% | +40.0% |
Q4 2017 | $802,000 | -2.8% | 15,728 | 0.0% | 0.01% | +25.0% |
Q3 2017 | $825,000 | +26.5% | 15,728 | +22.8% | 0.00% | -33.3% |
Q2 2017 | $652,000 | -15.7% | 12,809 | -26.4% | 0.01% | -14.3% |
Q1 2017 | $773,000 | +0.5% | 17,409 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $769,000 | +10.3% | 17,409 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $697,000 | -20.3% | 17,409 | -4.9% | 0.01% | -30.0% |
Q2 2016 | $874,000 | +17.6% | 18,309 | +3.4% | 0.01% | +25.0% |
Q1 2016 | $743,000 | -4.7% | 17,709 | 0.0% | 0.01% | +33.3% |
Q4 2015 | $780,000 | -42.5% | 17,709 | -37.7% | 0.01% | -50.0% |
Q3 2015 | $1,356,000 | -45.5% | 28,409 | -33.5% | 0.01% | -33.3% |
Q2 2015 | $2,489,000 | -5.0% | 42,709 | -17.7% | 0.02% | -5.3% |
Q1 2015 | $2,621,000 | +12.6% | 51,909 | +0.3% | 0.02% | +26.7% |
Q4 2014 | $2,328,000 | +23.0% | 51,775 | +0.8% | 0.02% | +25.0% |
Q3 2014 | $1,893,000 | -28.2% | 51,375 | -13.9% | 0.01% | -25.0% |
Q2 2014 | $2,635,000 | +10.5% | 59,675 | +8.8% | 0.02% | +6.7% |
Q1 2014 | $2,384,000 | -16.5% | 54,863 | -18.3% | 0.02% | -16.7% |
Q4 2013 | $2,854,000 | +26.9% | 67,163 | +1.5% | 0.02% | +28.6% |
Q3 2013 | $2,249,000 | +37.2% | 66,163 | +26.1% | 0.01% | +7.7% |
Q2 2013 | $1,639,000 | – | 52,463 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |